Neurophysiological effects of intracerebroventricular administration of urocortin

Peptides

Volumn 20, Issue 2, 1999, Pages 211-218

  Slawecki, C J ^a   Somes, C ^a   Rivier, J E ^a   Ehlers, C L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CRF; EEG; Event related potentials; Urocortin

Indexed keywords

ANOREXIGENIC AGENT; CENTRAL STIMULANT AGENT; CORTICOTROPIN RELEASING FACTOR; UROCORTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; COGNITION; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FRONTAL CORTEX; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0032805592     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00160-0     Document Type: Article

References (27)

1. Aulakh C.S., Hill J.L., Wozniak K.M., Murphy D.L. Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline. Psychopharmacology. 95:1988;313-317.
2. Aulakh C.S., Wozniak K.M., Hill J.L., Murphy D.L. Long-term imipramine treatment differentially affects fenfluramine-induced suppression of food intake and locomotor activity. Pharmacol. Biochem. Behav. 31:1988;97-101.
3. Bernardis L.L., Bellinger L.L. The lateral hypothalamic area revisited neuroanatomy, body weight regulation, neuroendocrinology, and metabolism . Neurosci. Biobehav. Rev. 17:1993;141-193.
4. Conrin J. The EEG effects of tobacco smoking a review . Clin. Electroenceph. 11:1980;180-187.
5. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
6. Ehlers C.L. EEG stability following corticotropin releasing factor in rats. Psychoneuroendocrinology. 11:1986;121-125.
7. Ehlers C.L., Chaplin R.I. EEG and ERP response to chronic ethanol exposure in rats. Psychopharmacology. 104:1991;67-74.
8. Ehlers C.L., Chaplin R.I., Lumeng L., Li T.K. Electrophysiological response to ethanol in P and NP rats. Alcohol: Clin. Exp. Res. 15:1991;739-744.
9. Ehlers C.L., Henriksen S.J., Wang M., Rivier J., Vale W., Bloom F.E. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res. 278:1983;332-336.
10. Ehlers C.L., Reed T.K., Henriksen S.J. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology. 42:1986;467-474.
11. Ehlers C.L., Somes C., Lopez A., Kirby D., Rivier J.E. Electrophysiological actions of neuropeptide Y and its analogs new measures for anxiolytic therapy . Neuropsychopharmacology. 17:1997;34-43.
12. Ehlers C.L., Somes C., Seifritz E., Rivier J.E. CRF/NPY interactions. A potential role in sleep dysregulation in depression and anxiety. Depression and Anxiety. 6:1997;1-9.
13. Herning R.I., Glover B.J., Koeppl B., Phillips R.L., London E.D. Cocaine-induced increases in EEG alpha and beta activity evidence for reduced cortical processing . Neuropsychopharmacology. 11:1994;1-9.
14. Knott V.J. Dynamic EEG changes during cigarette smoking. Neuropsychobiology. 19:1988;54-60.
15. Kozicz T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 391:1998;1-10.
16. Krijzer F.N.C.M., van der Molen R. Classification of psychotropic drugs by rat EEG analysis the anxiolytic profile in comparison to the antidepressant and neuroleptic profile . Neuropsychobiology. 18:1987;51-56.
17. Lorist M.M., Snel J., Kok A., Mulder G. Acute effects of caffeine on selective attention and visual search processes. Psychophysiology. 33:1996;354-361.
18. Lorist M.M., Snel J., Mulder G., Kok A. Aging, caffeine and information processing An event-related potential analysis . Electroenceph. Clin. Neurophysiol. 96:1995;453-467.
19. Moreau J.L., Kilpatrick G., Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. NeuroReport. 8:1997;1697-1701.
20. Nickel B., Schulze G., Szelenyi I. Effect of enantiomers of deprenyl (selegiline) and amphetamine on physical abuse liability and cortical electrical activity in rats. Neuropharm. 29:1990;983-992.
21. Pellegrino L.J., Pellegrino A.S., Cushman A.J. A stereotaxic atlas of the rat brain. 1979;Plenumm Press, New York.
22. Polich J. P300 in clinical applications Meaning, method, and measurement . Niedermeyer E., Lopes da Silva F. Electroencephalography Basic principles, clinical applications, and related fields . vol. 3:1993;1005-1018 William & Wilkins, Baltimore.
23. Robledo P., Lumeng L., Li T.K., Ehlers C.L. Effects of MK 801 and diazepam on the EEG of P and NP rats. Alcohol: Clin. Exp. Res. 18:1994;363-368.
24. Sebban C., Tesolin B., Shvaloff A., Lemaitre-Guardiola B. l-Fenfluramine and haloperidol in rats a qEEG comparison . Psychopharmacology. 98:1989;131-138.
25. Spina M., Merlo-Pilch E., Chan R.K.W., Basso A.M., Rivier J., Vale W., Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564.
26. Vaughan J.M., Donaldson C.J., Bittencourt J., Perrin M.H., Lewis K.A., Sutton S.W., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
27. Wolpaw J.R., Penry J.K. Effects of ethanol, caffeine and placebo on the auditory evoked response. Electroenceph. Clin. Neurophysiol. 44:1978;568-574.